Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q4 2026 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$281.62M$281.62Mderived−5.0% vs Q4 2025 Net Income$53.93M$53.93Mderived+7.6% vs Q4 2025 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$146,299,000−13.9% Operating Incomederived$75,492,000−14.6% Operating Cash Flowderived$42,841,000−30.7% Free Cash Flowderived$37,631,000−35.5% Margins · derivedGross margin51.9%−5.4 pt vs Q4 2025
Operating margin26.8%−3.0 pt vs Q4 2025
Net margin19.1%+2.2 pt vs Q4 2025
ended Mar 31, 2026 · filed May 14, 2026 · 44 d after period end